Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study
-
Published:2023-06
Issue:
Volume:60
Page:102010
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Hu Yongxian,
Zu Cheng,
Zhang Mingming,
Wei Guoqing,
Li Wei,
Fu Shan,
Hong Ruimin,
Zhou Linghui,
Wu Wenjun,
Cui Jiazhen,
Wang Dongrui,
Du Bing,
Liu Mingyao,
Zhang Jiqin,
Huang HeORCID
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献